What Are the Challenges in Developing Epigenetic Drugs?
Developing these drugs presents several challenges. One of the main obstacles is the lack of specificity, as these agents often affect multiple genes and pathways. Additionally, the effects of epigenetic changes are complex and can vary depending on the tissue type and the specific context of the disease. Understanding these complexities is crucial for developing safe and effective epigenetic therapies.
